Our exec team will attend JPM 2024 in San Francisco

I'm thrilled to announce that I, along with my esteemed colleagues Dr. Patrik Foerch, and Dr. Ben Owens, will be attending the annual JP Morgan Healthcare Investment Conference in San Francisco in 2024. We will be presenting updates on the rollout of our innovative HDX-MS technology for both small and large-molecule drug discovery. Our technology is specifically designed for intrinsically disordered proteins (IDPs), and we are excited to share our progress with our investors, pharma collaborators, and peer biotechnology companies.